Analyst Jack Allen works at BAIRD and is focused on the Healthcare sector with 19 price targets and ratings documented since 2021 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 58.33% with an average time for price targets to be met of 36 days.
Most recent stock forecast was given on TIL, at 01-Nov-2022.
Jack Allen best performing recommendations are on ALLO (ALLOGENE THERAPEUTICS, INC).
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS, INC) at 6/3/2022. The price target of $11 was fulfilled within 18 days with a profit of $2.68 (32.21%) receiving and performance score of 17.9.
Average potential price target upside